wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q30487546-A5D3D11E-EA58-4543-9A3A-08F471C8CA40
Q30487546-A5D3D11E-EA58-4543-9A3A-08F471C8CA40
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30487546-A5D3D11E-EA58-4543-9A3A-08F471C8CA40
Promoting Precision Cancer Medicine through a Community-Driven Knowledgebase.
P2860
Q30487546-A5D3D11E-EA58-4543-9A3A-08F471C8CA40
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30487546-A5D3D11E-EA58-4543-9A3A-08F471C8CA40
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fe5762c37cb19b7aef987a852c70074e77fe4d33
P2860
Phase II clinical trial results involving treatment with low-dose daily oral cyclophosphamide, weekly vinblastine, and rofecoxib in patients with advanced solid tumors.